Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive Mastoid Electric Stimulation for Meniere's Disease
NCT06001593Phase 2Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2023
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Meniere's disease (MD), sponsored by Seoul National University Hospital. Primary endpoints: Dizziness Visual Analogue Scale at 12 weeks, Video Head Impulse Test at 12 weeks and 2 more. Started Sep 2023; status: recruiting.
02
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT06001593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001593.